Dutch study sheds light on virus that causes SARS

By Michael Kahn

LONDON (Reuters) - Dutch researchers have built a three-dimensional model of a type of virus that causes SARS in a step that could one day help in the battle against the deadly disease.

The model, created using hepatitis coronavirus from mice, will help scientists understand severe acute respiratory syndrome (SARS), which appeared in China in 2002 and killed some 800 people globally before being brought under control.

“I think we can translate what we found for this virus to the SARS virus,” Berend Jan Bosch, a virologist at Utrecht University who worked on the study, said in a telephone interview on Monday.

“If you are going to study the SARS virus you will basically find the same features.”

The researchers reported their findings in the Proceedings of the National Academy of Sciences.

Coronaviruses cause diseases in animals and in people from the common cold to severe gastrointestinal illness. They also cause SARS which scientists believe, like influenza, initially came from an animal.

The 2002 outbreak of SARS is estimated to have cost as much as $100 billion. Quarantine and travel restrictions helped contain the disease.

Bosch and colleagues used a new type of electron microscopy to take images of the virus in a frozen state.

“Because we take so many pictures from different angles, we could combine the images to recreate the virus in 3D,” Bosch said.

The researchers also discovered that the virus’ outer coating or envelope, which it uses to fuse with and spread to healthy cells, is thicker than thought due to an extra internal layer.

Deciphering the structure of the mouse coronavirus is a basic finding but one that can allow researchers to better understand the human form of the virus, Bosch added.

“It is a broader understanding of the architecture of coronaviruses,” he said. “It is really fundamental knowledge.”

(Reporting by Michael Kahn; editing by Maggie Fox and Charles Dick)

Source

--------------------------------------------------------------------------------------------
Related Posts:


By Michael Kahn LONDON (Reuters) - Near-universal HIV tests and immediate drug treatment for people who test positive would almost eliminate transmission of the deadly virus within a decade, a computer model showed on Wednesday. Doing this would cost more initially but then save money down the road because there would be fewer HIV-infected people to treat,

Full Post: Universal HIV tests would have big impact: study
--------------------------------------------------------------------------------------------

By Andrew Quinn WASHINGTON (Reuters) - A global AIDS vaccine conference this week will seek fresh strategies against the HIV virus, with experts weighing the value of basic laboratory research against large-scale human clinical trials after a string of disappointments. Approaches focusing on “neutralizing antibodies” that would allow the human immune system to block infection completely, are

Full Post: AIDS vaccine focus shifts after disappointments
--------------------------------------------------------------------------------------------

LONDON (Reuters) - Genentech and Roche’s cancer drug Avastin can help find tumors as well as treat them, scientists said on Wednesday. After tagging the antibody drug with a radioactive tracer and injecting it into mice, researchers found it successfully targeted cancer cells and this enabled them to produce well-defined images of tumors during scanning. When compared

Full Post: Cancer drug Avastin may work as imaging tool too
--------------------------------------------------------------------------------------------

By Michael Kahn LONDON (Reuters) - An international research team has identified a tiny piece of genetic material that plays a key role in heart failure, and shown how an experimental compound prevents the condition in mice, scientists reported on Sunday. The researchers used a treatment from Regulus Therapeutics — a joint venture between U.S. biotech companies

Full Post: Gene “silencing” drug blocks heart disease in mice
--------------------------------------------------------------------------------------------

By Michael Kahn LONDON (Reuters) - Five centuries after Leonardo da Vinci’s intricate drawings transformed understanding of the human heart, a new computer model promises to do the same for modern-day cardiac care, experts say. The model — so realistic its four chambers beat in the same asymmetrical rhythm on screen as does a real heart in

Full Post: New cyber heart model recalls da Vinci’s sketches

Site Navigation

Most Read

Search